Scripps Research Logo

Robert Mc Millan, M.D.

Professor Emeritus
Department of Molecular Medicine
California Campus
Laboratory Website
Scripps VIVO Scientific Profile
@scripps.edu
(858) 784-9685

Professional Experience

2004-2017 Professor Emeritus, Molecular and Experimental Medicine (MEM), The Scripps Research Institute

Selected References

All Publications

Provan, D., Stasi, R., Newland, A. C., Blanchette, V. S., Bolton-Maggs, P., Bussel, J. B., Chong, B. H., Cines, D. B., Gernsheimer, T. B., Godeau, B., Grainger, J., Greer, I., et al. International consensus report on the investigation and management of primary immune thrombocytopenia. (2010). Blood, 115(2), 168-186.

McMillan, R. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production. (2009). Hematology-Oncology Clinics of North America, 23(6), 1163-1175.

Nugent, D., McMillan, R., Nichol, J. L. & Slichter, S. J. Pathogenesis of chronic immune thrombocytopenia: Increased platelet destruction and/or decreased platelet production. (2009). British Journal of Haematology, 146(6), 585-596.

Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D. M., Bussel, J. B., Cines, D. B., Chong, B. H., Cooper, N., Godeau, B., Lechner, K., et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. (2009). Blood, 113(11), 2386-2393.

Mathias, S. D., Gao, S. K., Miller, K. L., Cella, D., Snyder, C., Turner, R., Wu, A., Bussel, J. B., George, J. N., McMillan, R., Wysocki, D. K., Nichol, J. L. Impact of chronic immune thrombocytopenic purpura (itp) on health-related quality of life: A conceptual model starting with the patient perspective. (2008). Health and Quality of Life Outcomes, 6, 13. PMCID: PMC2275726.

McMillan, R., Bussel, J. B., George, J. N., Lalla, D. & Nichol, J. L. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. (2008). American Journal of Hematology, 83(2), 150-154.

Mathias, S. D., Bussel, J. B., George, J. N., McMillan, R., Okano, G. J. & Nichol, J. L. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation. (2007). Health and Quality of Life Outcomes, 5, 11. PMCID: PMC1808052.

Mathias, S. D., Bussel, J. B., George, J. N., McMillan, R., Okano, G. J. & Nichol, J. L. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: Psychometric testing in an open-label clinical trial. (2007). Clinical Therapeutics, 29(5), 950-962.

Cines, D. B. & McMillan, R. Pathogenesis of chronic immune thrombocytopenic purpura. (2007). Current Opinion in Hematology, 14(5), 511-514.

Bussel, J. B., Kuter, D. J., George, J. N., McMillan, R., Aledort, L. M., Conklin, G. T., Lichtin, A. E., Lyons, R. M., Nieva, J., Wasser, J. S., Wiznitzer, I., Kelly, R., et al. Amg 531, a thrombopoiesis-stimulating protein, for chronic itp. (2006). New England Journal of Medicine, 355(16), 1672-1681.